Toronto-based
Aleafia Health Inc.(
TSX-V.ALEF) – a global leader in cannabis wellness products and services – has reported its financial results for the three and nine months ending September 30
th, 2021.
The Company’s 2021 third quarter unaudited, consolidated financial statements and management discussion and analysis will be available in the Investors section of the Company’s website at aleafiahealth.com and will be filed on SEDAR and available at
sedar.com.
Financial Highlights:
- $9.6 million net revenue with an improved sales mix focused on the high-growth adult-use and recurring medical cannabis sales channels.
- 2,044% y/y increase in adult-use cannabis net revenue.
- 31% y/y increase in medical cannabis net revenue
- Top 10 in national market share in pre-rolls achieved subsequent to the reporting period.
- Top 10 in national adult-use market share in edibles and oils categories.
- Outdoor harvest produced average yield on THC-dominant dried flower of 22%
- SG&A expenses declined 24% over the previous quarter.
- Strengthened product portfolio with a total of 35 and 46 SKUs listed in Ontario and Alberta respectively by January 2022.
Complete information
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.